Literature DB >> 17624565

On-Board Imager-based MammoSite treatment verification.

Jadwiga Wojcicka1, Rafael Yankelevich, Stephen Iorio, Alfred Tinger.   

Abstract

Contemporary radiation oncology departments are often lacking a conventional simulator due to common use of virtual simulation and recent implementation of image guided radiation therapy. A protocol based on MammoSite method was developed using CT based planning, a Source Position Simulator (SPS) with a Simulator Wire and a linear accelerator based On-Board Imager (OBI) for daily verification. After MammoSite balloon implantation, the patient undergoes a CT study. The images are evaluated for tissue conformance, balloon symmetry, and balloon surface to skin distance according to the departmental procedure. Prior to the CT study the SPS is attached to the transfer tube that in turn is attached to the balloon catheter. The length from the indexer to the first dwell position is measured using the simulator wire with X-ray markers. After the CT study is performed, the data set is sent to the Varian Eclipse treatment planning system (TPS) and to the Nucletron PLATO brachytherapy planning system. The reference digitally reconstructed radiographs (DRRs) of anterior and lateral setup fields are created using Eclipse TPS and are immediately available on the OBI console via the Varian Vision integrated system. The source dwell position coinciding with the balloon center is identified in the CT dataset, followed by the offset calculation, catheter reconstruction, dose points placement and dwell time calculation. OBI fluoroscopy images are acquired and marked as initial. Prior to each treatment fraction balloon diameter and symmetry are evaluated using OBI fluoroscopy and tools available on the OBI console. Acquired images are compared with reference DRRs and/or initial OBI images. The whole process from initial evaluation to daily verification is filmless and does not undermine the precision of the procedure. This verification time does not exceed 10 min. The balloon diameter correlates well (within 1 mm) between initial CT and OBI verification images. The balloon symmetry is defined with 1 mm accuracy using existing OBI console tools. It is feasible to use OBI based simulation for the MammoSite balloon placement evaluation, balloon integrity daily verification, and treatment dwell position coincidence with balloon center. This verification is a rapid process and is an alternative to the conventional simulator based technique. The simulator wire with X-ray markers for the SPS is the recommended tool for the CT based MammoSite procedure.

Entities:  

Mesh:

Year:  2007        PMID: 17624565     DOI: 10.1007/s11517-007-0202-1

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   3.079


  7 in total

1.  Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator.

Authors:  Gregory K Edmundson; Frank A Vicini; Peter Y Chen; Christina Mitchell; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-15       Impact factor: 7.038

2.  Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience.

Authors:  Douglas W Arthur; Derrick Koo; Robert D Zwicker; Shidong Tong; Harry D Bear; Brian J Kaplan; Brian D Kavanagh; Laurel A Warwicke; Diane Holdford; Cyrus Amir; Kellie J Archer; Rupert K Schmidt-Ullrich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

3.  Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer.

Authors:  T A King; J S Bolton; R R Kuske; G M Fuhrman; T G Scroggins; X Z Jiang
Journal:  Am J Surg       Date:  2000-10       Impact factor: 2.565

4.  Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.

Authors:  Jennifer L Harper; Joseph M Jenrette; Kenneth N Vanek; Eric G Aguero; William E Gillanders
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-01-01       Impact factor: 7.038

5.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

6.  Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy.

Authors:  Martin Keisch; Frank Vicini; Robert R Kuske; Mary Hebert; Julia White; Coral Quiet; Doug Arthur; Troy Scroggins; Oscar Streeter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-02-01       Impact factor: 7.038

7.  Factors influencing cosmetic results after conservation therapy for breast cancer.

Authors:  M E Taylor; C A Perez; K J Halverson; R R Kuske; G W Philpott; D M Garcia; J E Mortimer; R J Myerson; D Radford; C Rush
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-02-15       Impact factor: 7.038

  7 in total
  1 in total

1.  World Congress on Medical Physics and Biomedical Engineering (WC2006, Seoul).

Authors:  Eung Je Woo; Hee-Joung Kim; Jos A E Spaan
Journal:  Med Biol Eng Comput       Date:  2007-11-15       Impact factor: 2.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.